---
source: /Users/byron/projects/papers/10.1038_s41467-025-65692-1/metadata_raw.json
relative: papers/10.1038_s41467-025-65692-1/metadata_raw.json
generated_at: 2025-12-23 10:28
---

```json
{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T15:05:54Z","timestamp":1764255954411,"version":"3.46.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Intestinal P-glycoprotein (P-gp\/\n                    <jats:italic>ABCB1<\/jats:italic>\n                    ) is a key barrier limiting xenobiotic absorption, yet its functional decline with aging is poorly understood. Here, we show that gut microbiota dysbiosis contributes to age-associated P-gp deficiency. Integrated multi-omics analyses of human cohorts and murine models identify\n                    <jats:italic>Odoribacter splanchnicus<\/jats:italic>\n                    (\n                    <jats:italic>O. splanchnicus<\/jats:italic>\n                    ) as a key commensal species whose depletion impairs intestinal P-gp function. Mechanistically,\n                    <jats:italic>O. splanchnicus<\/jats:italic>\n                    encodes GDP-mannose 4, 6-dehydratase (GMDS) and GDP-L-fucose synthase (TSTA3), enabling microbial biosynthesis of GDP-L-fucose. This metabolite directly promotes phosphorylation of the eukaryotic translation initiation factor 4E (eIF4E) and activates c-Jun-driven\n                    <jats:italic>ABCB1<\/jats:italic>\n                    expression, thereby restoring xenobiotic efflux. These findings establish a microbiota-metabolite-transporter signaling axis that maintains intestinal detoxification, suggesting that targeting either microbes or metabolites could help prevent adverse drug reactions in older adults.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-65692-1","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T14:05:45Z","timestamp":1764252345000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Odoribacter splanchnicus rescues aging-related intestinal P-glycoprotein damage via GDP-L-fucose secretion"],"prefix":"10.1038","volume":"16","author":[{"given":"Cheng","family":"Cui","sequence":"first","affiliation":[]},{"given":"Lu","family":"Fang","sequence":"additional","affiliation":[]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[]},{"given":"Xuan","family":"Lai","sequence":"additional","affiliation":[]},{"given":"Ruitao","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Rong","family":"Miao","sequence":"additional","affiliation":[]},{"given":"Gaofei","family":"Hu","sequence":"additional","affiliation":[]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Jie En Valerie","family":"Sia","sequence":"additional","affiliation":[]},{"given":"Jingcheng","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Haodi","family":"Chai","sequence":"additional","affiliation":[]},{"given":"Xinyi","family":"Wu","sequence":"additional","affiliation":[]},{"given":"Zijin","family":"Lin","sequence":"additional","affiliation":[]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Haiyan","family":"Li","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4473-6936","authenticated-orcid":false,"given":"Lemin","family":"Zheng","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0608-8192","authenticated-orcid":false,"given":"Dongyang","family":"Liu","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"65692_CR1","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1001\/jamainternmed.2017.0911","volume":"177","author":"C Carroll","year":"2017","unstructured":"Carroll, C. & Hassanin, A. Polypharmacy in the elderly-when good drugs lead to bad outcomes: a teachable moment. JAMA Intern. Med. 177, 871 (2017).","journal-title":"JAMA Intern. Med."},{"key":"65692_CR2","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1111\/bph.15612","volume":"178","author":"T Miyake","year":"2021","unstructured":"Miyake, T. et al. Quantitative prediction of P-glycoprotein-mediated drug\u2013drug interactions and intestinal absorption using humanized mice. Br. J. Pharm. 178, 4335\u20134351 (2021).","journal-title":"Br. J. Pharm."},{"key":"65692_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-021-01137-3","volume":"9","author":"SE Foley","year":"2021","unstructured":"Foley, S. E. et al. Gut microbiota regulation of P-glycoprotein in the intestinal epithelium in maintenance of homeostasis. Microbiome 9, 183 (2021).","journal-title":"Microbiome"},{"key":"65692_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/cpt.1916","volume":"109","author":"MJ Zamek-Gliszczynski","year":"2021","unstructured":"Zamek-Gliszczynski, M. J. et al. Intestinal P-gp and putative hepatic OATP1B induction: international transporter consortium perspective on drug development implications. Clin. Pharm. Ther. 109, 55\u201364 (2021).","journal-title":"Clin. Pharm. Ther."},{"key":"65692_CR5","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/cpt.1213","volume":"104","author":"X Chu","year":"2018","unstructured":"Chu, X., Galetin, A., Zamek-Gliszczynski, M. J., Zhang, L. & Tweedie, D. J. Dabigatran etexilate and digoxin: comparison as clinical probe substrates for evaluation of P-gp inhibition. Clin. Pharm. Ther. 104, 788\u2013792 (2018).","journal-title":"Clin. Pharm. Ther."},{"key":"65692_CR6","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/bjh.17899","volume":"195","author":"E Kampouraki","year":"2021","unstructured":"Kampouraki, E., Avery, P., Biss, T., Wynne, H. & Kamali, F. Assessment of exposure to direct oral anticoagulants in elderly hospitalised patients. Br. J. Haematol. 195, 790\u2013801 (2021).","journal-title":"Br. J. Haematol."},{"key":"65692_CR7","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s11739-023-03375-9","volume":"18","author":"F Catalani","year":"2023","unstructured":"Catalani, F. et al. Efficacy and safety of direct oral anticoagulants in older adults with atrial fibrillation: a prospective single-centre cohort study. Intern Emerg. Med. 18, 1941\u20131949 (2023).","journal-title":"Intern Emerg. Med."},{"key":"65692_CR8","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1002\/cpt.2369","volume":"110","author":"N Gronich","year":"2021","unstructured":"Gronich, N., Stein, N. & Muszkat, M. Association between use of pharmacokinetic-interacting drugs and effectiveness and safety of direct acting oral anticoagulants: nested case-control study. Clin. Pharm. Ther. 110, 1526\u20131536 (2021).","journal-title":"Clin. Pharm. Ther."},{"key":"65692_CR9","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jacc.2021.06.056","volume":"78","author":"JB Schwartz","year":"2021","unstructured":"Schwartz, J. B., Kogan, S. C. & Fang, M. C. Preventing bleeding with direct-acting oral anticoagulants. J. Am. Coll. Cardiol. 78, e127 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"65692_CR10","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1172\/JCI106457","volume":"49","author":"TW Smith","year":"1970","unstructured":"Smith, T. W. & Haber, E. Digoxin intoxication: the relationship of clinical presentation to serum digoxin concentration. J. Clin. Invest. 49, 2377\u20132386 (1970).","journal-title":"J. Clin. Invest."},{"key":"65692_CR11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/aps.2010.51","volume":"31","author":"XD Zhou","year":"2010","unstructured":"Zhou, X. D., Gao, Y., Guan, Z., Li, Z. D. & Li, J. Population pharmacokinetic model of digoxin in older Chinese patients and its application in clinical practice. Acta Pharm. Sin. 31, 753\u2013758 (2010).","journal-title":"Acta Pharm. Sin."},{"key":"65692_CR12","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.amjmed.2019.04.022","volume":"132","author":"S Angraal","year":"2019","unstructured":"Angraal, S. et al. Digoxin use and associated adverse events among older adults. Am. J. Med 132, 1191\u20131198 (2019).","journal-title":"Am. J. Med"},{"key":"65692_CR13","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","volume":"570","author":"M Zimmermann","year":"2019","unstructured":"Zimmermann, M., Zimmermann-Kogadeeva, M., Wegmann, R. & Goodman, A. L. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature 570, 462\u2013467 (2019).","journal-title":"Nature"},{"key":"65692_CR14","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.cell.2020.05.001","volume":"181","author":"B Javdan","year":"2020","unstructured":"Javdan, B. et al. Personalized mapping of drug metabolism by the human gut microbiome. Cell 181, 1661\u20131679.e22 (2020).","journal-title":"Cell"},{"key":"65692_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg8357","volume":"16","author":"AA Verdegaal","year":"2024","unstructured":"Verdegaal, A. A. & Goodman, A. L. Integrating the gut microbiome and pharmacology. Sci. Transl. Med. 16, eadg8357 (2024).","journal-title":"Sci. Transl. Med."},{"key":"65692_CR16","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1126\/science.aac8469","volume":"350","author":"PW O\u2019Toole","year":"2015","unstructured":"O\u2019Toole, P. W. & Jeffery, I. B. Gut microbiota and aging. Science 350, 1214\u20131215 (2015).","journal-title":"Science"},{"key":"65692_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.chom.2020.07.013","volume":"28","author":"EN DeJong","year":"2020","unstructured":"DeJong, E. N., Surette, M. G. & Bowdish, D. The gut microbiota and unhealthy aging: disentangling cause from consequence. Cell Host Microbe 28, 180\u2013189 (2020).","journal-title":"Cell Host Microbe"},{"key":"65692_CR18","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s40262-022-01184-5","volume":"61","author":"C Cui","year":"2022","unstructured":"Cui, C. et al. Assessment of aging-related function variations of p-gp transporter in old-elderly chinese chf patients based on modeling and simulation. Clin. Pharmacokinet. 61, 1789\u20131800 (2022).","journal-title":"Clin. Pharmacokinet."},{"key":"65692_CR19","doi-asserted-by":"publisher","first-page":"g4670","DOI":"10.1136\/bmj.g4670","volume":"349","author":"D Cohen","year":"2014","unstructured":"Cohen, D. Dabigatran: how the drug company withheld important analyses. BMJ 349, g4670 (2014).","journal-title":"BMJ"},{"key":"65692_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41586-021-03852-1","volume":"597","author":"R Elmentaite","year":"2021","unstructured":"Elmentaite, R. et al. Cells of the human intestinal tract mapped across space and time. Nature 597, 250\u2013255 (2021).","journal-title":"Nature"},{"key":"65692_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.addr.2018.08.013","volume":"135","author":"M Chetty","year":"2018","unstructured":"Chetty, M. et al. Physiologically based pharmacokinetic modelling to guide drug delivery in older people. Adv. Drug Deliv. Rev. 135, 85\u201396 (2018).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"65692_CR22","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s40262-020-00867-1","volume":"59","author":"M Elmeliegy","year":"2020","unstructured":"Elmeliegy, M., Vourvahis, M., Guo, C. & Wang, D. D. Effect of P-glycoprotein (P-gp) inducers on exposure of P-gp substrates: review of clinical drug\u2013drug interaction studies. Clin. Pharmacokinet. 59, 699\u2013714 (2020).","journal-title":"Clin. Pharmacokinet."},{"key":"65692_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.clpt.2003.09.012","volume":"75","author":"C Marzolini","year":"2004","unstructured":"Marzolini, C., Paus, E., Buclin, T. & Kim, R. B. Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin. Pharm. Ther. 75, 13\u201333 (2004).","journal-title":"Clin. Pharm. Ther."},{"key":"65692_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.mce.2004.12.005","volume":"231","author":"Y Miki","year":"2005","unstructured":"Miki, Y., Suzuki, T., Tazawa, C., Blumberg, B. & Sasano, H. Steroid and xenobiotic receptor (SXR), cytochrome P450 3A4 and multidrug resistance gene 1 in human adult and fetal tissues. Mol. Cell Endocrinol. 231, 75\u201385 (2005).","journal-title":"Mol. Cell Endocrinol."},{"key":"65692_CR25","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1111\/bcp.14609","volume":"87","author":"C Cui","year":"2021","unstructured":"Cui, C. et al. Development of a physiologically based pharmacokinetic (PBPK) population model for Chinese elderly subjects. Br. J. Clin. Pharm. 87, 2711\u20132722 (2021).","journal-title":"Br. J. Clin. Pharm."},{"key":"65692_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrmicro.2016.17","volume":"14","author":"P Spanogiannopoulos","year":"2016","unstructured":"Spanogiannopoulos, P., Bess, E. N., Carmody, R. N. & Turnbaugh, P. J. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat. Rev. Microbiol. 14, 273\u2013287 (2016).","journal-title":"Nat. Rev. Microbiol."},{"key":"65692_CR27","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2278225","volume":"15","author":"MY Lim","year":"2023","unstructured":"Lim, M. Y. & Nam, Y. D. Gut microbiome in healthy aging versus those associated with frailty. Gut Microbes 15, 2278225 (2023).","journal-title":"Gut Microbes"},{"key":"65692_CR28","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.1021\/acs.molpharmaceut.8b00875","volume":"15","author":"EF Enright","year":"2018","unstructured":"Enright, E. F. et al. Gut microbiota-mediated bile acid transformations alter the cellular response to multidrug resistant transporter substrates in vitro: focus on P-glycoprotein. Mol. Pharm. 15, 5711\u20135727 (2018).","journal-title":"Mol. Pharm."},{"key":"65692_CR29","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3389\/fmicb.2020.00597","volume":"11","author":"T Yuan","year":"2020","unstructured":"Yuan, T., Wang, J., Chen, L., Shan, J. & Di, L. Lactobacillus murinus improved the bioavailability of orally administered glycyrrhizic acid in rats. Front. Microbiol 11, 597 (2020).","journal-title":"Front. Microbiol"},{"key":"65692_CR30","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1126\/science.291.5505.881","volume":"291","author":"LV Hooper","year":"2001","unstructured":"Hooper, L. V. et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 291, 881\u2013884 (2001).","journal-title":"Science"},{"key":"65692_CR31","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.cub.2016.04.016","volume":"26","author":"E Biagi","year":"2016","unstructured":"Biagi, E. et al. Gut microbiota and extreme longevity. Curr. Biol. 26, 1480\u20131485 (2016).","journal-title":"Curr. Biol."},{"key":"65692_CR32","doi-asserted-by":"publisher","first-page":"e00325","DOI":"10.1128\/mSystems.00325-19","volume":"4","author":"L Wu","year":"2019","unstructured":"Wu, L. et al. A cross-sectional study of compositional and functional profiles of gut microbiota in Sardinian centenarians. mSystems 4, e00325\u201319 (2019).","journal-title":"mSystems"},{"key":"65692_CR33","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/s41591-024-03038-y","volume":"30","author":"T Wang","year":"2024","unstructured":"Wang, T. et al. Divergent age-associated and metabolism-associated gut microbiomesignatures modulate cardiovascular disease risk. Nat. Med. 30, 1722\u20131731 (2024).","journal-title":"Nat. Med."},{"key":"65692_CR34","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41575-022-00605-x","volume":"19","author":"TS Ghosh","year":"2022","unstructured":"Ghosh, T. S., Shanahan, F. & O\u2019Toole, P. W. The gut microbiome as a modulator of healthy ageing. Nat. Rev. Gastroenterol. Hepatol. 19, 565\u2013584 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"65692_CR35","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/s43587-022-00306-9","volume":"2","author":"TS Ghosh","year":"2022","unstructured":"Ghosh, T. S., Shanahan, F. & O\u2019Toole, P. W. Toward an improved definition of a healthy microbiome for healthy aging. Nat. Aging 2, 1054\u20131069 (2022).","journal-title":"Nat. Aging"},{"key":"65692_CR36","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41586-021-03832-5","volume":"599","author":"Y Sato","year":"2021","unstructured":"Sato, Y. et al. Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians. Nature 599, 458\u2013464 (2021).","journal-title":"Nature"},{"key":"65692_CR37","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2107288","volume":"14","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. The landscape in the gut microbiome of long-lived families reveals new insights on longevity and aging\u2014relevant neural and immune function. Gut Microbes 14, 2107288 (2022).","journal-title":"Gut Microbes"},{"key":"65692_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14028","volume":"22","author":"L Sun","year":"2023","unstructured":"Sun, L. et al. Age-dependent changes in the gut microbiota and serum metabolome correlate with renal function and human aging. Aging Cell 22, e14028 (2023).","journal-title":"Aging Cell"},{"key":"65692_CR39","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.chom.2021.03.016","volume":"29","author":"C Xing","year":"2021","unstructured":"Xing, C. et al. Microbiota regulate innate immune signaling and protective immunity against cancer. Cell Host Microbe 29, 959\u2013974.e7 (2021).","journal-title":"Cell Host Microbe"},{"key":"65692_CR40","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2292254","volume":"16","author":"X Wu","year":"2024","unstructured":"Wu, X., Zhang, T., Zhang, T. & Park, S. The impact of gut microbiome enterotypes on ulcerative colitis: identifying key bacterial species and revealing species co-occurrence networks using machine learning. Gut Microbes 16, 2292254 (2024).","journal-title":"Gut Microbes"},{"key":"65692_CR41","doi-asserted-by":"crossref","unstructured":"Hajra, D. et al. Odoribacter splanchnicus mitigates Salmonella-induced gut inflammation and its associated pathogenesis via its secreted bacteriocin. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/2024.08.23.609322v1 (2024).","DOI":"10.1101\/2024.08.23.609322"},{"key":"65692_CR42","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3390\/microorganisms13040815","volume":"13","author":"J Li","year":"2025","unstructured":"Li, J. et al. Odoribacter splanchnicus\u2014a next-generation probiotic candidate. Microorganisms 13, 815 (2025).","journal-title":"Microorganisms"},{"key":"65692_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13568-019-0798-1","volume":"9","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. Cell-free enzymatic synthesis of GDP-L-fucose from mannose. AMB Express 9, 74 (2019).","journal-title":"AMB Express"},{"key":"65692_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32505-8","volume":"13","author":"L Dong","year":"2022","unstructured":"Dong, L. et al. Mannose ameliorates experimental colitis by protecting intestinal barrier integrity. Nat. Commun. 13, 4804 (2022).","journal-title":"Nat. Commun."},{"key":"65692_CR45","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1182\/blood.V95.11.3641.011a52g_3641_3643","volume":"95","author":"A Etzioni","year":"2000","unstructured":"Etzioni, A. & Tonetti, M. Fucose supplementation in leukocyte adhesion deficiency type II. Blood 95, 3641\u20133643 (2000).","journal-title":"Blood"},{"key":"65692_CR46","doi-asserted-by":"publisher","first-page":"137393","DOI":"10.1016\/j.foodchem.2023.137393","volume":"433","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Research progress on the functions, preparation and detection methods of L-fucose. Food Chem. 433, 137393 (2024).","journal-title":"Food Chem."},{"key":"65692_CR47","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/cpt.3497","volume":"117","author":"M Zhang","year":"2025","unstructured":"Zhang, M. et al. Distribution characteristics and impacting factors of drug CYP enzymes and transporters in the gastrointestinal tract of chinese healthy subjects. Clin. Pharm. Ther. 117, 676\u2013689 (2025).","journal-title":"Clin. Pharm. Ther."},{"key":"65692_CR48","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1517\/17425255.4.4.395","volume":"4","author":"H Sun","year":"2008","unstructured":"Sun, H., Chow, E. C., Liu, S., Du, Y. & Pang, K. S. The Caco-2 cell monolayer: usefulness and limitations. Expert Opin. Drug Metab. Toxicol. 4, 395\u2013411 (2008).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"65692_CR49","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0169-409X(96)00414-0","volume":"22","author":"JH Ismael","year":"1996","unstructured":"Ismael, J. H. & Li, J. B. Carrier-mediated transport and efflux mechanisms in Caco-2 cells. Adv. Drug Deliv. Rev. 22, 53\u201366 (1996).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"65692_CR50","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/nprot.2016.051","volume":"11","author":"S Forli","year":"2016","unstructured":"Forli, S. et al. Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nat. Protoc. 11, 905\u2013919 (2016).","journal-title":"Nat. Protoc."},{"key":"65692_CR51","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785\u20132791 (2009).","journal-title":"J. Comput. Chem."},{"key":"65692_CR52","doi-asserted-by":"crossref","unstructured":"Dong, Y. et al. Structural basis of ubiquitin modification by the Legionella effector SdeA. Nature. 557, 674\u2013678 (2018).","DOI":"10.1038\/s41586-018-0146-7"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65692-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65692-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65692-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T15:03:21Z","timestamp":1764255801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65692-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["65692"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-65692-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"type":"electronic","value":"2041-1723"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declared no competing interests","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10665"}}
```
